Paris Cedex 15

France

63 total trials 33 recruiting

Filter these 63 trials by phase, condition, sponsor and more.

Open in Search →

Phase III trial of laryngeal preservation comparating chemotherapy followed by radiotherapy to chemotherapy administrated during radiotherap … Ended recruitment

2024-513976-16-00 5 2015-06-26 squamous cell carcinomas of the larynx or hypopharynx locally advance
A Phase 3, Randomized, Crossover, Open-Label, Active-Controlled Study of Sepiapterin versus Sapropterin in Participants With Phenylketonuria … Ended

2023-506238-61-00 5 2024-05-10 Phenylketonuria
A study to learn if baxdrostat works at reducing blood pressure and is safe in people with high blood pressure Ended

2023-505499-32-00 5 2024-03-08 Uncontrolled hypertension (uTHN) defined as blood pressure that remain
A trial to compare the efficacy and safety of aficamten (CK-3773274) compared with metoprolol succinate in adults with symptomatic hypertrop … Ended

2023-504809-37-00 5 2024-02-07 Symptomatic Obstructive Hypertrophic Cardiomyopathy
A Phase 2a Study to Evaluate Setanaxib in Patients with Alport Syndrome Ended

2023-505292-73-00 4 2024-01-10 Alport syndrome
A study to learn more about how well BAY 3018250 works and how safe it is for people with proximal deep vein thrombosis Ended

2023-503315-15-00 4 2023-12-20 Thrombolysis of symptomatic proximal vein thrombosis
COTRIVAP - Efficacy of cotrimoxazole as a de-escalation treatment of Ventilator-Associated Pneumonia in intensive care unit Ended

2023-505108-52-00 5 2023-12-20 Intensive Care
A clinical study of bemcentinib with standard of care chemoimmunotherapy in untreated advanced/metastatic non-small cell lung cancer patient … Ended

2024-511007-41-00 9 2023-10-03 Untreated advanced or metastatic non-squamous non-small cell lung canc
Evaluation of Amivantamab Infusion Related Reaction Mitigation Ended

2023-506578-11-00 4 2023-04-25 EGFR-mutated Advanced or Metastatic Non-small Cell Lung Cancer
A Phase 3, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of intravenous efzofitimod in patients wit … Ended

2023-506039-13-00 5 2023-04-12 pulmonary sarcoidosis
A Randomized, Double-blind, Placebo-controlled, Multinational, Phase 3 Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects … Ended

2024-514761-19-00 5 2023-01-25 Idiopathic Pulmonary Fibrosis
Potential of FX06 to improve disease severity in Acute Respiratory Distress Syndrome patients (Ixion 2.0) Ended

2024-519104-27-00 4 2022-03-08 Acute Respiratory Distress Syndrome (ARDS)
A Long-term Safety Extension Study of Mavacamten (MYK-461) in Adults with Hypertrophic Cardiomyopathy Who Have Completed the MAVERICKHCM (MY … Ended

2022-502858-14-00 5 2019-09-05 Hypertrophic cardiomyopathy
MULTICENTER RANDOMIZED PHASE II STUDY COMPARING THE EFFECTIVENESS AND TOLERANCE OF AVELUMAB VERSUS STANDARD 2nd LINE TREATMENT CHEMOTHERAPY … Ended

2024-517362-41-00 4 2018-04-24 COLORECTAL METASTATIC CANCER WITH MICROSATELLITE INSTABILITY
A Phase 3 Study of Nivolumab plus Ipilimumab Versus Sunitinib in untreated Subjects with Advanced or Metastatic Renal Cell Carcinoma (RCC) Ended

2023-504761-23-00 5 2014-11-19 Advanced or metastatic renal cell carcinoma

Showing 49–63 of 63 trials